Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
Merli M, Ageno W, Sessa F, Salvini M, Caramazza D, Mora B, Rossi A, Rovelli C, Passamonti F, Grossi P. Merli M, et al. Among authors: caramazza d. Ann Hematol. 2020 Aug;99(8):1951-1952. doi: 10.1007/s00277-020-04130-2. Epub 2020 Jun 11. Ann Hematol. 2020. PMID: 32529284 Free PMC article. No abstract available.
Clinical predictors of outcome in MPN.
Passamonti F, Maffioli M, Merli M, Ferrario A, Caramazza D. Passamonti F, et al. Among authors: caramazza d. Hematol Oncol Clin North Am. 2012 Oct;26(5):1101-16. doi: 10.1016/j.hoc.2012.07.009. Epub 2012 Aug 28. Hematol Oncol Clin North Am. 2012. PMID: 23009940 Review.
Novel agents in indolent lymphomas.
Merli M, Ferrario A, Basilico C, Maffioli M, Caramazza D, Appio L, Arcaini L, Passamonti F. Merli M, et al. Among authors: caramazza d. Ther Adv Hematol. 2013 Apr;4(2):133-48. doi: 10.1177/2040620712466865. Ther Adv Hematol. 2013. PMID: 23610620 Free PMC article.
It is time to change thrombosis risk assessment for PV and ET?
Passamonti F, Caramazza D, Mora B, Casalone R, Maffioli M. Passamonti F, et al. Among authors: caramazza d. Best Pract Res Clin Haematol. 2014 Jun;27(2):121-7. doi: 10.1016/j.beha.2014.07.005. Epub 2014 Jul 18. Best Pract Res Clin Haematol. 2014. PMID: 25189723 Review.
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients.
Mora B, Guglielmelli P, Kuykendall A, Rumi E, Maffioli M, Palandri F, De Stefano V, Caramella M, Salmoiraghi S, Kiladjian JJ, Gotlib J, Iurlo A, Cervantes F, Ruggeri M, Silver RT, Albano F, Benevolo G, Ross DM, Della Porta MG, Devos T, Rotunno G, Komrokji RS, Casetti IC, Merli M, Brociner M, Caramazza D, Auteri G, Barbui T, Cattaneo D, Bertù L, Arcaini L, Vannucchi AM, Passamonti F. Mora B, et al. Among authors: caramazza d. Leukemia. 2022 Oct;36(10):2453-2460. doi: 10.1038/s41375-022-01673-3. Epub 2022 Aug 30. Leukemia. 2022. PMID: 36042316
Looking for CALR mutations in familial myeloproliferative neoplasms.
Maffioli M, Genoni A, Caramazza D, Mora B, Bussini A, Merli M, Giorgino T, Casalone R, Passamonti F. Maffioli M, et al. Among authors: caramazza d. Leukemia. 2014 Jun;28(6):1357-60. doi: 10.1038/leu.2014.33. Epub 2014 Jan 20. Leukemia. 2014. PMID: 24441291 No abstract available.
Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.
Passamonti F, Maffioli M, Cervantes F, Vannucchi AM, Morra E, Barbui T, Caramazza D, Pieri L, Rumi E, Gisslinger H, Knoops L, Kiladjian JJ, Mora B, Hollaender N, Pascutto C, Harrison C, Cazzola M. Passamonti F, et al. Among authors: caramazza d. Blood. 2014 Mar 20;123(12):1833-5. doi: 10.1182/blood-2013-12-544411. Epub 2014 Jan 17. Blood. 2014. PMID: 24443442 Free article. Clinical Trial.
60 results